Missouri Judge Greenlights Bayer’s $7.25 Billion Settlement

A Missouri judge approved Bayer's $7.25 billion settlement on Friday. This settlement resolves lawsuits claiming that its Roundup weedkiller causes cancer. Judge Timothy Boyer called the settlement "fair, reasonable, and adequate." The agreement aims to compensate users who developed non-Hodgkin lymphoma from Roundup exposure and those who may get sick in the future.

Key Details

Bayer plans to pay the settlement over 21 years. Individual payouts will range from $10,000 to $165,000. The amounts will depend on factors like the severity of the illness and the length of exposure to the product. Bayer has already spent about $10 billion to settle earlier lawsuits related to Roundup, which it acquired through its purchase of Monsanto in 2018.

The settlement follows a Supreme Court ruling in June that favored Bayer. The court stated that federal regulations preempt state law claims about labeling. This decision overturned a $1.25 million award to a Missouri man who claimed Roundup caused his cancer. Bayer has faced about 65,000 claims in U.S. courts from individuals alleging cancer due to Roundup use. The company insists that glyphosate, the active ingredient in Roundup, is safe and does not cause cancer. This is despite the International Agency for Research on Cancer labeling it as a probable human carcinogen.

Background

Christopher Seeger, a lawyer for cancer patients, said that the approval provides "guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice." Some attorneys have criticized the settlement amounts as too low. However, Judge Boyer stressed the need to provide timely compensation to seriously ill patients.

Market Impact

The settlement may stabilize Bayer's share price, which has dropped significantly since acquiring Monsanto. Resolving these claims could reduce future litigation risks and improve investor sentiment. Watch for updates on any potential appeals against the settlement ruling.

Based on reporting by: bbc.co.uk, bbc.com

Share: